A Digital Health Intervention to Improve Symptoms and Physical Activity During Breast Radiation
Launched by UNIVERSITY OF WASHINGTON · Jan 9, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating a digital health program designed to help patients with breast cancer manage symptoms and stay more active while receiving radiation treatment. Many patients experience tiredness, known as cancer-related fatigue, which can affect their quality of life. The program, called Integrative Medicine at Home (IM@Home), offers online cardio fitness and yoga classes that aim to reduce fatigue and other distressing symptoms. The trial is particularly focused on helping patients from different backgrounds, especially those who may feel that their situation affects their ability to be active and manage their symptoms.
To participate in this trial, you need to be at least 18 years old and currently receiving radiation therapy for breast cancer. It's important that you can understand English, either on your own or with the help of a caregiver. If you join the study, you'll have access to this virtual program and can expect support in improving your physical activity and managing symptoms during your treatment. The trial is currently looking for participants, so it's a great opportunity for those who are eligible to potentially benefit from these resources.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18 years old.
- • Ability to understand English, or has a caregiver who understands English.
- • Ability to understand and willingness to sign a written informed consent document, virtually or in-person.
- • Current breast cancer diagnosis.
- • Currently receiving radiation with curative intent (including partial breast, whole breast, or regional nodal radiation).
- Exclusion Criteria:
- • Patients who are non-English speaking that would prevent their participation in IM@Home.
- • Patients with metastatic disease (i.e. stage IV).
About University Of Washington
The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
Spokane Valley, Washington, United States
Patients applied
Trial Officials
Erin Gillespie, MD, MPH
Principal Investigator
Fred Hutch/University of Washington Cancer Consortium
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported